*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
E229 - Hyperfunction of pituitary gland, unspecified - as a primary or secondary diagnosis code | ||
---|---|---|
OUTCOMES | ||
Avg. LOS | ||
Readmission Rate (%) | ||
Unplanned Readmission Rate (%) | 14.75 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 885: PSYCHOSES | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 614: ADRENAL AND PITUITARY PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|
Total Hospitalizations at DRG | 1,100,860 | ||
Total Hospitalizations with ICD E229 - Hyperfunction of pituitary gland, unspecified | 32 | ||
DRG Share of Total Hospitalizations | 3.35 | ||
% of Total ICD E229 - Hyperfunction of pituitary gland, unspecified in DRG | 13.22 | ||
Avg LOS at DRG | 11.86 | ||
Avg LOS with ICD E229 - Hyperfunction of pituitary gland, unspecified | 19.09 | ||
Readmission Rate at DRG | 27.58 | ||
Readmission Rate with ICD E229 - Hyperfunction of pituitary gland, unspecified | NA | ||
Unplanned Readmission Rate at DRG | 13.34 | ||
Unplanned Readmission Rate with ICD E229 - Hyperfunction of pituitary gland, unspecified | NA | ||
Total Medicare payments at DRG | $9,312,828,663 | ||
Total Medicare payments with ICD E229 - Hyperfunction of pituitary gland, unspecified | $364,331 | ||
Total Medicare payment per Day at DRG | $713 | ||
Total Medicare payment per Day with ICD E229 - Hyperfunction of pituitary gland, unspecified | $596 | ||
Total Medicare payment per Hospitalization at DRG | $8,460 | ||
Total Medicare payment per Hospitalization with ICD E229 - Hyperfunction of pituitary gland, unspecified | $11,385 | ||
Total Medicare Charges at DRG | $32,341,464,302 | ||
Total Medicare Charges with ICD E229 - Hyperfunction of pituitary gland, unspecified | $1,228,413 | ||
Avg Charges at DRG | $29,378 | ||
Avg Charges with ICD E229 - Hyperfunction of pituitary gland, unspecified | $38,388 | ||
Mortality Rate at DRG | 0.04 | ||
Mortality Rate with ICD E229 - Hyperfunction of pituitary gland, unspecified | NA | ||
SNF Discharge Rate at DRG | 5.83 | ||
SNF Discharge Rate with ICD E229 - Hyperfunction of pituitary gland, unspecified | NA | ||
Home Discharge Rate at DRG | 79.47 | ||
Home Discharge Rate with ICD E229 - Hyperfunction of pituitary gland, unspecified | 65.63 |